These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16182746)

  • 41. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE; Marino G; Kuo PC; Plotkin JS; Rustgi VK; Lu AD; Edwards E; Taranto S; Johnson LB
    Liver Transpl; 2001 Sep; 7(9):762-8. PubMed ID: 11552208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation.
    File E; Mehra M; Nair S; Dumas-Hicks D; Perrillo R
    Transplantation; 2003 Oct; 76(7):1096-100. PubMed ID: 14557759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation.
    Machicao VI; Krishna M; Bonatti H; Aqel BA; Nguyen JH; Weigand SD; Rosser BG; Hughes C; Dickson RC
    Liver Transpl; 2004 May; 10(5):599-606. PubMed ID: 15108251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
    Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
    Charlton M; Ruppert K; Belle SH; Bass N; Schafer D; Wiesner RH; Detre K; Wei Y; Everhart J
    Liver Transpl; 2004 Sep; 10(9):1120-30. PubMed ID: 15350002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
    Khettry U; Huang WY; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
    Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of hepatitis C-infected grafts in liver transplantation.
    Arenas JI; Vargas HE; Rakela J
    Liver Transpl; 2003 Nov; 9(11):S48-51. PubMed ID: 14586895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of extended criteria donors in hepatitis C virus-positive recipients.
    Berenguer M
    Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
    Thuluvath PJ; Krok KL; Segev DL; Yoo HY
    Liver Transpl; 2007 May; 13(5):719-24. PubMed ID: 17457933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria.
    Cescon M; Grazi GL; Cucchetti A; Ravaioli M; Ercolani G; Vivarelli M; D'Errico A; Del Gaudio M; Pinna AD
    Liver Transpl; 2008 May; 14(5):672-9. PubMed ID: 18433035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of imported liver allografts and impact on patient access to liver transplantation.
    Akoad M; Wagener M; Francis F; Ahmed J; Ulizio D; Cacciarelli TV
    Transplant Proc; 2006 Dec; 38(10):3564-6. PubMed ID: 17175332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.